Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Val Lowe
- Study ID
- NCT04786223
- Phase
- PHASE2
- Status
- Enrolling By Invitation
Conditions
- Alzheimer Dementia (AD)
- Lewy Body Dementia (LBD)
Eligibility Criteria
- Sex
- ALL
- Age
- 60 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- C-11 ER-176 — DRUGParticipants will receive a one-time administration of C-11 ER176 and undergo a PET/CT imaging study. Participants may be invited to return for an additional administration of C-11 ER176 and undergo an additional PET/CT imaging study.
- Blood Test — DIAGNOSTIC_TESTParticipants will undergo a one time venipuncture blood collection to evaluate the presence of inflammatory and genetic markers.
Study Details
This study is being done to research the usefulness of PET/CT imaging for measuring brain inflammation and its relation to Alzheimer's Disease Dementia and related dementias. Additionally, researchers are looking to learn more about the side effects of a new radioactive tracer (radiotracer) C-11 ER176.
Key Dates
- Start date
- Mar 30, 2021
- Status verified
- May 2026
- Primary completion
- Mar 31, 2029
- Completion
- Mar 31, 2030
Study Design
- Enrollment
- 125 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Other: C-11 ER176 PET/CTC-11 ER176 is an investigational radiopharmaceutical that will be produced under cGMP in the Mayo Clinic Cyclotron Facility. The imaging agent (C-11 ER176) will be administered on an outpatient basis. It will be administered at a single time IV prior to the PET imaging.
Primary Outcome Measure
Determine if neuroinflammation, as measured by C-11 ER176 SUVr and inflammatory blood test measurements, is correlated with an increase in AB plaque, as measured by C-11 PiB SUVr. [ Time Frame: 4 years ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | - |
Find similar trials in Rochester, MN
By research site
Related Studies
- Genetic Studies of Early-onset DementiaRecruiting · Columbia University · New York, New York
- 18F-mFBG Cardiac Uptake With Lewy Body DementiaPHASE2 · Recruiting · Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) · Houston, Texas
- A Trial to Test Intermittent Deep Brain Stimulation of Nucleus Basalis of Meynert to Treat Alzheimers.PHASE1 · Recruiting · Augusta University · Augusta, Georgia
- Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy BodiesNot Yet Recruiting · BioSensics · Lutherville, Maryland